An interventional study of Registered dietitian and On-line video program in IBS - Irritable Bowel Syndrome, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-12-14.
Sponsored by Mayo Clinic · Not applicable, Interventional, and Supportive care
Researchers are trying to determine the best course of action regarding the dietary management with a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP diet) for irritable bowel syndrome.
An analysis of different educational programs providing information on the low FODMAP diet will be performed.
1,062 studies on the registry are indexed under Irritable Bowel Syndrome; 190 are open to participants now.
This study's enrollment of 49 is below the median of 71 across 853 interventional studies indexed under Irritable Bowel Syndrome.
Browse Irritable Bowel Syndrome studies →Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.
Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet in person by a registered dietitian
Other: Registered dietitian
Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet using an on-line video program
Other: On-line video program
Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet by a printed handout
Other: Printed handout
Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet in a dietitian-led group setting
Other: Dietitian-led group
Education on low FODMAP diet is provided in person by a registered dietitian who is an expert on the low FODMAP diet
Education on low FODMAP diet is provided by an on-line program via a link sent through email
Education on low FODMAP diet is provided through printed handout material at the initial visit.
Education on low FODMAP diet is provided in a dietitian-led group setting
Improvement in IBS symptoms
Change in IBS symptoms will be measured from baseline to the end of study using the validated IBS symptoms severity scale (IBS-SS). This is a visual analog scale from 0-100. The primary outcome measure is improvement in symptom scores from end of study to baseline.
Time frame: Baseline, end of study approximately 8 to 10 weeks
Plan to share: No
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mayo Clinic